MedTrace Logo

Quantum Natural Family Planning Pilot

NCT03908697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-03-24

No results posted yet for this study

Summary

•The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices to monitor the menstrual cycle.

Conditions

  • Fertility Disorders

Interventions

DEVICE

Mira monitor comparison to ClearBlue monitor

Testing first morning urine with hormone test sticks at home

Sponsors & Collaborators

  • Quanovate Tech Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2021-02-28
Completion
2021-04-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908697 on ClinicalTrials.gov